Allergology International

Papers
(The TQCC of Allergology International is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Three-year prognoses after low-dose oral food challenge for cow's milk101
Exacerbated signs of atopic dermatitis with gut dysbiosis predominate in male than in female adult patients82
On non-biologic treatment clinical remission in adult-onset asthma: A 20-year cohort study in Taiwan66
Efficacy and safety of systemic targeted therapies for atopic dermatitis in children: A systematic review and meta-analysis62
Effects of raw seafood on the risk of hypersensitivity reaction recurrence in patients with an Anisakis allergy: A retrospective observational study in Japan56
Clinical remission in severe asthma treated with biologics and macrolides: Definition, prevalence, associated factors, and future perspectives55
Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome52
Analysis of drug-induced anaphylaxis cases using the Japanese Adverse Drug Event Report (JADER) database – secondary publication50
Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunction45
A diagnostic score for eosinophilic granulomatosis with polyangiitis among eosinophilic disorders42
High-dimensional immune profiling of atopic dermatitis reveals a dysfunctional OX40+ regulatory T cell subset37
Hands at risk: Decoding clinical profiles and occupational causes in chronic hand eczema35
Gut microbiota contributes to the maintenance of sublingually induced regulatory T cells and tolerance in mice34
IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice32
Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in a murine atopic dermatitis-like dermatitis32
Urinary prostaglandin D2 metabolite as a potential diagnostic biomarker for perioperative anaphylaxis: A pilot study32
Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study30
Factors contributing to the diagnosis and onset prediction of perennial allergic rhinitis in high-risk children: A sub-analysis of the CHIBA study30
Fibrin and fibrinogen degradation products/D-dimer ratio can be a useful marker for differentiating an acute attack of hereditary angioedema from thrombotic conditions30
Exacerbation rates in Japanese patients with obstructive lung disease: A subanalysis of the prospective, observational NOVELTY study29
Filaggrin-deficient rats generated using zinc-finger nucleases spontaneously exhibit dry scaly skin28
A message from the new Editor-in-Chief28
YTHDF1 regulates the proliferation and differentiation of keratinocytes via the PI3K/AKT signaling pathway in atopic dermatitis27
The immune network across organs27
Emerging cell and molecular targets for treating mucus hypersecretion in asthma27
Urticaria and basophils27
Mucus plugging on computed tomography and the sputum microbiome in patients with asthma, chronic obstructive pulmonary disease, and asthma-COPD overlap26
Addictive behavior is not a comorbidity of chronic spontaneous urticaria25
Epidemiology and risk factors of non-esophageal eosinophilic gastrointestinal diseases in Japan: A population-based study25
A micropeptide TREMP encoded by lincR-PPP2R5C promotes Th2 cell differentiation by interacting with PYCR1 in allergic airway inflammation25
Clinical findings and subjective symptoms in patients with bronchial asthma and chemical hypersensitivity in Japan24
Functional gastrointestinal disorders are associated with capsaicin cough sensitivity in severe asthma24
Improvement of atopic dermatitis-like symptoms in a murine model via the chromogranin A-derived peptide catestatin23
Mouse hygiene status–A tale of two environments for mast cells and allergy22
Clonal differentiation of plasmablasts undergoing oral immunotherapy in patients with milk allergy22
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)21
Skin symptoms during the pollen seasons and their association with the severity of seasonal allergic rhinitis in Yamanashi, Japan21
Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo)20
Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study20
Critical pathomechanisms of NSAID-exacerbated respiratory disease (N-ERD) clarified by treatment with omalizumab, an anti-IgE antibody20
Metabolome-based severity assessment of seasonal allergic rhinitis using nasal secretions19
Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan19
Executive summary: Japanese pediatric guideline for the treatment and management of asthma (JPGL) 202018
Current situation of anaphylaxis in Japan: Data from the anaphylaxis registry of training and teaching facilities certified by the Japanese Society of Allergology – secondary publication18
Discrepancies between the asthma control test and quality of life scores among biologic- and nonbiologic-treated asthma patients18
Updates on the ocular manifestations and treatment of SJS/TEN18
Current topics on urticaria, and urticaria-related diseases introduced in the Japanese urticaria clinical practice guidelines17
Role of nasal polyp-derived innate lymphoid cells in staphylococcal enterotoxin-induced cellular responses17
Claudin-3 deficiency inhibits allergic responses in an ovalbumin-induced asthma mouse model17
Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis17
B cell development and longevity of IgE plasma cells16
Lysophosphatidic acid (LPA)/LPA1 axis induces goblet cell hyperplasia via activation of pulmonary neuroendocrine cells in a chronic mouse model of asthma16
Dysbiosis of the human skin mycobiome in patients receiving systemic IL-23 inhibitors16
Is intramuscular adrenaline used promptly against drug-induced anaphylaxis? A perspective from recent analyses of fatal cases in Japan16
Recent progress in allergen immunotherapy16
The dual aspects of IgD in the development of tolerance and the pathogenesis of allergic diseases16
Severe cutaneous adverse reactions: From clinical recognition to prevention strategies15
The IL-36 cytokine family: From barrier immunity to therapeutic target in inflammatory diseases15
Gut microbiota of one-and-a-half-year-old food-allergic and healthy children15
Lipocalin-2 promotes neutrophilic inflammation in nasal polyps and its value as biomarker15
Long-term impact of a birch/alder/hazel or birch-only liquid sublingual immunotherapy on birch-family pollen respiratory allergy: A real-world study15
In vitro cross-reactivity between hen's egg and quail's egg in children with hen's egg allergy14
S100A8 enhances IL-1β production from nasal epithelial cells in eosinophilic chronic rhinosinusitis14
T follicular helper cells and IgE14
Clinical remission in asthma and related diseases: Current landscape and future perspectives14
Potential determinants of T helper 2 markers and their distribution in school-aged children14
Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma13
Two cases of edible cricket allergy: Antigen analysis and cross-reactivity with shrimp and mite allergens13
Airway epithelial STAT3 inhibits allergic inflammation via upregulation of stearoyl-CoA desaturase 113
Cluster analysis of phenotypes, job exposure, and inflammatory patterns in elderly and nonelderly asthma patients13
Small airway dysfunction in asthma based on oscillometry13
Control of immunity and allergy by steroid hormones12
Dietary patterns and food allergies associated with asthma in adults: Findings from an internet-based dietary survey in Japan12
Management of severe asthma during the COVID-19 pandemic: A retrospective study using a Japanese database12
Detrimental impact of the IL-33/ST2 axis in an animal infection model with Cryptococcus neoformans12
Elevated MS4A2 and IgE interaction in nasal polyps contributing to poor postoperative prognosis in patients with eosinophilic chronic rhinosinusitis12
Analysis of the relationship between comorbid obstructive sleep apnea and clinical outcomes in patients with asthma in Japan12
Allergic bronchopulmonary mycosis associated with a novel pathogen: Bjerkandera adusta12
Group 2 innate lymphoid cells in human asthma12
Characteristics of food protein-induced enterocolitis syndrome with metabolic acidosis: A case–control study12
Multiple at-risk groups have lower lung function during the grass pollen season12
Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma12
Heparin-like compounds improve the biophysical properties of eosinophilic mucus11
Distinct subsets of innate lymphoid cells in nasal polyp11
15-Hydroxyeicosatrienoic acid induces nasal congestion by changing vascular functions in mice11
Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy11
Early versus delayed dupilumab differentially restores IL-13–induced airway barrier dysfunction11
Welcome to “Circadian Immunology & Allergology”: Why timing matters in diagnosing and treating allergies11
Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)11
Characterization of eosinophils and natural killer cells in nasal polyps and peripheral blood in eosinophilic chronic rhinosinusitis patients11
Role of bronchial hyperresponsiveness in patients with obstructive sleep apnea with asthma-like symptoms11
Insights from the COCOA birth cohort: The origins of childhood allergic diseases and future perspectives11
Executive summary: Japanese guidelines for allergic rhinitis 202011
Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study11
0.37417817115784